276 related articles for article (PubMed ID: 30733324)
1. Evaluation of
Nabulsi NB; Holden D; Zheng MQ; Bois F; Lin SF; Najafzadeh S; Gao H; Ropchan J; Lara-Jaime T; Labaree D; Shirali A; Slieker L; Jesudason C; Barth V; Navarro A; Kant N; Carson RE; Huang Y
J Nucl Med; 2019 Aug; 60(8):1147-1153. PubMed ID: 30733324
[TBL] [Abstract][Full Text] [Related]
2. First-in-Human Assessment of
Naganawa M; Nabulsi N; Henry S; Matuskey D; Lin SF; Slieker L; Schwarz AJ; Kant N; Jesudason C; Ruley K; Navarro A; Gao H; Ropchan J; Labaree D; Carson RE; Huang Y
J Nucl Med; 2021 Apr; 62(4):553-560. PubMed ID: 32859711
[TBL] [Abstract][Full Text] [Related]
3. Novel Kappa Opioid Receptor Agonist as Improved PET Radiotracer: Development and in Vivo Evaluation.
Li S; Zheng MQ; Naganawa M; Gao H; Pracitto R; Shirali A; Lin SF; Teng JK; Ropchan J; Huang Y
Mol Pharm; 2019 Apr; 16(4):1523-1531. PubMed ID: 30726092
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.
Nabulsi NB; Mercier J; Holden D; Carré S; Najafzadeh S; Vandergeten MC; Lin SF; Deo A; Price N; Wood M; Lara-Jaime T; Montel F; Laruelle M; Carson RE; Hannestad J; Huang Y
J Nucl Med; 2016 May; 57(5):777-84. PubMed ID: 26848175
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.
Chen L; Nabulsi N; Naganawa M; Zasadny K; Skaddan MB; Zhang L; Najafzadeh S; Lin SF; Helal CJ; Boyden TL; Chang C; Ropchan J; Carson RE; Villalobos A; Huang Y
J Nucl Med; 2016 Sep; 57(9):1448-53. PubMed ID: 27199356
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Pharmacological Characterization and In Vivo Validation of LSN3172176 a Novel M1 Selective Muscarinic Receptor Agonist Tracer Molecule for Positron Emission Tomography.
Mogg AJ; Eessalu T; Johnson M; Wright R; Sanger HE; Xiao H; Crabtree MG; Smith A; Colvin EM; Schober D; Gehlert D; Jesudason C; Goldsmith PJ; Johnson MP; Felder CC; Barth VN; Broad LM
J Pharmacol Exp Ther; 2018 Jun; 365(3):602-613. PubMed ID: 29643252
[TBL] [Abstract][Full Text] [Related]
7. Novel
Li S; Cai Z; Zheng MQ; Holden D; Naganawa M; Lin SF; Ropchan J; Labaree D; Kapinos M; Lara-Jaime T; Navarro A; Huang Y
J Nucl Med; 2018 Jan; 59(1):140-146. PubMed ID: 28747521
[TBL] [Abstract][Full Text] [Related]
8. The Search for a Subtype-Selective PET Imaging Agent for the GABA
Lin SF; Bois F; Holden D; Nabulsi N; Pracitto R; Gao H; Kapinos M; Teng JK; Shirali A; Ropchan J; Carson RE; Elmore CS; Vasdev N; Huang Y
Mol Imaging; 2017; 16():1536012117731258. PubMed ID: 28929924
[TBL] [Abstract][Full Text] [Related]
9. PET Imaging Estimates of Regional Acetylcholine Concentration Variation in Living Human Brain.
Smart K; Naganawa M; Baldassarri SR; Nabulsi N; Ropchan J; Najafzadeh S; Gao H; Navarro A; Barth V; Esterlis I; Cosgrove KP; Huang Y; Carson RE; Hillmer AT
Cereb Cortex; 2021 May; 31(6):2787-2798. PubMed ID: 33442731
[TBL] [Abstract][Full Text] [Related]
10. Characterization in nonhuman primates of (R)-[
Zheng M; Ahmed H; Smart K; Xu Y; Holden D; Kapinos M; Felchner Z; Haider A; Tamagnan G; Carson RE; Huang Y; Ametamey SM
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2153-2162. PubMed ID: 35107627
[TBL] [Abstract][Full Text] [Related]
11. An Improved Antagonist Radiotracer for the κ-Opioid Receptor: Synthesis and Characterization of (11)C-LY2459989.
Zheng MQ; Kim SJ; Holden D; Lin SF; Need A; Rash K; Barth V; Mitch C; Navarro A; Kapinos M; Maloney K; Ropchan J; Carson RE; Huang Y
J Nucl Med; 2014 Jul; 55(7):1185-91. PubMed ID: 24854795
[TBL] [Abstract][Full Text] [Related]
12. Development and In Vivo Evaluation of a κ-Opioid Receptor Agonist as a PET Radiotracer with Superior Imaging Characteristics.
Li S; Zheng MQ; Naganawa M; Kim S; Gao H; Kapinos M; Labaree D; Huang Y
J Nucl Med; 2019 Jul; 60(7):1023-1030. PubMed ID: 30630942
[TBL] [Abstract][Full Text] [Related]
13. PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates.
Hillmer AT; Zheng MQ; Li S; Scheunemann M; Lin SF; Holden D; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Carson RE; Brust P; Huang Y
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):537-47. PubMed ID: 26455500
[TBL] [Abstract][Full Text] [Related]
14. Further evaluation of [11C]MP-10 as a radiotracer for phosphodiesterase 10A: PET imaging study in rhesus monkeys and brain tissue metabolite analysis.
Lin SF; Labaree D; Chen MK; Holden D; Gallezot JD; Kapinos M; Teng JK; Najafzadeh S; Plisson C; Rabiner EA; Gunn RN; Carson RE; Huang Y
Synapse; 2015 Feb; 69(2):86-95. PubMed ID: 25450608
[TBL] [Abstract][Full Text] [Related]
15. Preclinical Evaluation and Nonhuman Primate Receptor Occupancy Study of
Kolb HC; Barret O; Bhattacharya A; Chen G; Constantinescu C; Huang C; Letavic M; Tamagnan G; Xia CA; Zhang W; Szardenings AK
J Nucl Med; 2019 Aug; 60(8):1154-1159. PubMed ID: 30733317
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging.
Zheng MQ; Nabulsi N; Kim SJ; Tomasi G; Lin SF; Mitch C; Quimby S; Barth V; Rash K; Masters J; Navarro A; Seest E; Morris ED; Carson RE; Huang Y
J Nucl Med; 2013 Mar; 54(3):455-63. PubMed ID: 23353688
[TBL] [Abstract][Full Text] [Related]
17. PET Imaging Evaluation of Four σ
Baum E; Cai Z; Bois F; Holden D; Lin SF; Lara-Jaime T; Kapinos M; Chen Y; Deuther-Conrad W; Fischer S; Dukic-Stefanovic S; Bunse P; Wünsch B; Brust P; Jia H; Huang Y
J Nucl Med; 2017 Jun; 58(6):982-988. PubMed ID: 28232607
[TBL] [Abstract][Full Text] [Related]
18. Kinetic Modeling and Test-Retest Reproducibility of
Naganawa M; Li S; Nabulsi N; Lin SF; Labaree D; Ropchan J; Gao H; Mei M; Henry S; Matuskey D; Carson RE; Huang Y
J Nucl Med; 2020 Nov; 61(11):1636-1642. PubMed ID: 32169917
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of 11C-BU99008, a PET ligand for the imidazoline2 binding sites in rhesus brain.
Parker CA; Nabulsi N; Holden D; Lin SF; Cass T; Labaree D; Kealey S; Gee AD; Husbands SM; Quelch D; Carson RE; Nutt DJ; Huang Y; Tyacke RJ
J Nucl Med; 2014 May; 55(5):838-44. PubMed ID: 24711648
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates.
Bois F; Gallezot JD; Zheng MQ; Lin SF; Esterlis I; Cosgrove KP; Carson RE; Huang Y
Nucl Med Biol; 2015 Jun; 42(6):570-7. PubMed ID: 25858513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
